Exchange: NASDAQ·Updated 07:30 PM EDT
IMCR logo

IMCR Immunocore Holdings PLC - ADR

$32.00
$0.30
(0.93%)
Today
Closed $32.00
$0.00
(0.00%)
After Hours
EarningsNov 5
Mkt Cap$1.65B
Vol475,903.00

About IMCR

Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. the firm's lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.
52

Neutral Sentiment

How do you feel about IMCR?

Advertisement|Remove ads.